Share

NIKE, Inc. (NKE.NYSE) AI OPINIONS & ADVISOR ANALYSIS

Read and compare the 14 individual AI Advisor deep-dive reports, including their forecast paths, ratings, price targets, and reasoning.

Updated on 20 September 2026Deep analysis 20 September 2026

Publisher

Russlan Ramdowar

25 min readAudit All Past Forecasts

14 AI Advisor Reports

Select an advisor report.

SynthesizerCombines all advisor views

Synthesis of 14 independent opinions

Diversity of ModelsSame approach, varied models

Diversity of FrameworksDifferent investing styles

AI Researcher

Opus 5

Universal Investor AI

The Polymath Framework

Model rating

Buy

5-Year Return Est.

+83.9%

Includes 3.21% annual net dividend contribution

1. Investment Thesis — Base Case

The central tension is that Nike is simultaneously cheaper and worse than the crowd believes. Reported earnings are inflated by a tariff recovery, so the true multiple on trough earnings is near 22x — but the trough itself is contractually targeted for repair by a CFO paid in basis points of FY2027 EBIT margin. Base case: revenue stays roughly flat through FY2028, China stabilises at a permanently smaller base, and operating margin grinds from about 6% underlying toward 10-11% by FY2030 on cost action and full-price mix, not volume heroics.

Underlying recovers from roughly $1.60 in FY2027 toward $2.70-2.90 by FY2030-31.
Applying an 19-20x mature-brand multiple to that base supports a mid-$50s share price.
Cross-check: $55 implies about $82B market value on $48B revenue — 1.7x sales, below Nike's own history.

Historical prices and published forecast

Observed price
Published advisor forecast

Observed prices and the selected advisor's published projection share a split-adjusted price basis. Prices after the forecast start are later observations, not information known at publication. Forecasts are uncertain. Values in USD.

View chart values

Historical prices and published forecast — published chart values
Series	Date	Value (USD)
Observed price	2021-09-15	158
Observed price	2021-09-28	147
Observed price	2021-10-11	155
Observed price	2021-11-01	171
Observed price	2021-11-10	168
Observed price	2021-11-19	175
Observed price	2021-12-06	170
Observed price	2021-12-15	164
Observed price	2021-12-28	168
Observed price	2022-01-18	146
Observed price	2022-01-31	147
Observed price	2022-02-09	142
Observed price	2022-02-18	144
Observed price	2022-03-11	124
Observed price	2022-03-15	123
Observed price	2022-03-28	135
Observed price	2022-04-19	135
Observed price	2022-04-28	122
Observed price	2022-05-19	109
Observed price	2022-05-28	115
Observed price	2022-06-06	120
Observed price	2022-06-23	107
Observed price	2022-07-02	103
Observed price	2022-07-19	111
Observed price	2022-07-23	110
Observed price	2022-08-14	116
Observed price	2022-08-18	115
Observed price	2022-09-05	105
Observed price	2022-09-18	107
Observed price	2022-10-01	84.9
Observed price	2022-10-09	86.9
Observed price	2022-10-27	92.5
Observed price	2022-11-04	91.6
Observed price	2022-11-26	107
Observed price	2022-12-05	110
Observed price	2022-12-22	116
Observed price	2022-12-26	117
Observed price	2023-01-13	129
Observed price	2023-01-30	129
Observed price	2023-02-07	123
Observed price	2023-02-16	125
Observed price	2023-03-10	118
Observed price	2023-03-14	119
Observed price	2023-03-18	124
Observed price	2023-04-09	122
Observed price	2023-05-01	127
Observed price	2023-05-05	127
Observed price	2023-05-27	107
Observed price	2023-06-09	107
Observed price	2023-06-17	111
Observed price	2023-06-26	112
Observed price	2023-07-09	106
Observed price	2023-07-31	110
Observed price	2023-08-13	107
Observed price	2023-08-17	105
Observed price	2023-09-08	97.6
Observed price	2023-09-12	96.3
Observed price	2023-09-25	90.5
Observed price	2023-10-08	97.8
Observed price	2023-10-21	104
Observed price	2023-11-03	104
Observed price	2023-11-25	108
Observed price	2023-11-29	111
Observed price	2023-12-16	122
Observed price	2023-12-25	108
Observed price	2024-01-15	102
Observed price	2024-01-20	101
Observed price	2024-02-10	106
Observed price	2024-02-15	106
Observed price	2024-03-07	99.1
Observed price	2024-03-12	101
Observed price	2024-04-02	90.4
Observed price	2024-04-07	90.3
Observed price	2024-04-20	94.4
Observed price	2024-05-07	93.4
Observed price	2024-05-16	91.8
Observed price	2024-05-29	93.2
Observed price	2024-06-19	96.5
Observed price	2024-06-24	95.2
Observed price	2024-07-15	71.6
Observed price	2024-08-06	72.7
Observed price	2024-08-10	76.5
Observed price	2024-08-23	84.2
Observed price	2024-09-05	80.5
Observed price	2024-09-10	79.1
Observed price	2024-09-27	88.2
Observed price	2024-10-14	83.5
Observed price	2024-10-27	78.6
Observed price	2024-10-31	78.1
Observed price	2024-11-18	74.2
Observed price	2024-12-01	79.0
Observed price	2024-12-18	77.1
Observed price	2024-12-22	76.9
Observed price	2025-01-13	71.2
Observed price	2025-01-17	71.4
Observed price	2025-01-30	76.8
Observed price	2025-02-12	73.1
Observed price	2025-02-25	80.1
Observed price	2025-03-10	74.7
Observed price	2025-03-28	63.3
Observed price	2025-04-05	57.8
Observed price	2025-04-10	54.4
Observed price	2025-05-01	58.5
Observed price	2025-05-19	62.5
Observed price	2025-06-09	63.0
Observed price	2025-06-18	60.6
Observed price	2025-06-22	60.4
Observed price	2025-07-05	75.1
Observed price	2025-07-18	73.8
Observed price	2025-07-27	76.5
Observed price	2025-08-26	78.5
Observed price	2025-09-04	74.6
Observed price	2025-09-08	74.2
Observed price	2025-09-25	70.6
Observed price	2025-10-04	71.6
Observed price	2025-10-08	66.5
Observed price	2025-11-08	61.3
Observed price	2025-11-12	65.3
Observed price	2025-11-25	64.2
Observed price	2025-12-12	66.9
Observed price	2025-12-25	59.2
Observed price	2026-01-12	65.6
Observed price	2026-01-20	65.4
Observed price	2026-02-02	61.0
Observed price	2026-02-20	65.3
Observed price	2026-03-05	58.0
Observed price	2026-03-09	56.3
Observed price	2026-03-26	52.2
Observed price	2026-04-04	46.3
Observed price	2026-04-08	44.0
Observed price	2026-05-13	42.4
Observed price	2026-05-22	44.7
Observed price	2026-05-30	46.1
Observed price	2026-06-04	43.6
Observed price	2026-06-25	40.9
Observed price	2026-07-12	43.8
Observed price	2026-07-17	43.7
Observed price	2026-08-07	41.8
Observed price	2026-08-20	40.7
Observed price	2026-09-02	38.7
Observed price	2026-09-07	38.2
Observed price	2026-09-15	35.8
Observed price	2026-09-24	36.0
Observed price	2026-09-25	35.8
Published advisor forecast	2026-09-18	35.5
Published advisor forecast	2026-12-18	33.7
Published advisor forecast	2027-03-18	34.4
Published advisor forecast	2027-06-18	35.8
Published advisor forecast	2027-09-18	37.2
Published advisor forecast	2027-12-18	39.1
Published advisor forecast	2028-03-18	40.3
Published advisor forecast	2028-06-18	41.9
Published advisor forecast	2028-09-18	43.1
Published advisor forecast	2028-12-18	44.4
Published advisor forecast	2029-03-18	45.3
Published advisor forecast	2029-06-18	46.7
Published advisor forecast	2029-09-18	47.6
Published advisor forecast	2029-12-18	49.0
Published advisor forecast	2030-03-18	50.0
Published advisor forecast	2030-06-18	51.0
Published advisor forecast	2030-09-18	52.0
Published advisor forecast	2030-12-18	53.1
Published advisor forecast	2031-03-18	53.6
Published advisor forecast	2031-06-18	54.7
Published advisor forecast	2031-09-18	55.8

2. Scenarios & Signals

Bull case

The bull case activates when margin recovery and China stabilisation arrive in the same fiscal year. Cost programmes deliver 200 basis points of EBIT margin, the Los Angeles 2028 Olympics amplifies a rebuilt running and basketball slate, and full-price sell-through returns. Free cash flow then exceeds $4B, the buyback restarts at scale, and the market re-rates Nike from cyclical turnaround back toward quality compounder. EPS near $3.20 on 22x supports a share price above $70.

Bear case

The bear case activates if cost cutting buys margin at the expense of relevance. Demand-creation restraint accelerates share loss below 21%, China keeps contracting, and wholesale partners reduce open-to-buy. slips under $2B while the dividend consumes $2.4B, forcing a freeze that triggers mechanical selling from income mandates. Earnings settle near $1.40 and the market applies a mature-licensor multiple, leaving the shares in the mid-$20s with no obvious catalyst.

Current crowd narrative

The settled belief is that Nike is a broken whose turnaround keeps slipping one more quarter. Sell-side targets span $23 to $94 with a Neutral composite, and every recent revision cuts. The anchoring bias is the reported 16.9x P/E, which investors treat as cheap without noticing that a one-off tariff recovery supplied roughly a quarter of FY2026 .

Alpha-gap assessment

The crowd underestimates these shares, but for a different reason than the bulls advance. The bull error is thinking Nike is cheap at 16.9x; strip the tariff credit and it is near 22x depressed earnings. The overlooked evidence is the 's compensation contract, which pays for FY2027 EBIT margin growth in basis points. That converts an aspirational turnaround into a contractually incentivised cost programme against a margin base roughly six points below FY2024 — high-probability recovery the market is pricing as a hope.

Convergence catalyst

The October 1, 2026 FQ1 print followed by the November Investor Day is the recognition event: the first gross-margin line uncontaminated by tariff recovery. Sustained year-over-year EBIT margin expansion on declining revenue would prove cost-led recovery is real. First sign of repricing: downgrade flow stopping, not target hikes.

Paywalled preview begins: Macro-regime alignment

From this section to the end-of-preview notice below, research is provided as simplified HTML text and tables. Full access provides the complete interactive interface, charts and additional datasets.

Sentiment and regime

Greed and fear sentiment: -0.6
Expected volatility regime: high_erratic
Convergence-cycle position: capitulation

Primary drivers

Primary drivers supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
CFO PAID IN Basis Points	David Denton's package ties a $4M performance award to FY2027 adjusted operating-margin growth in basis points above FY2026 [evidence memo]. That incentive geometry points straight at SG&A, demand-creation efficiency and supply-chain cost, not revenue vanity. With FY2026 operating margin at 8.19% reported and roughly 6% underlying versus 12.29% in FY2024, each recovered point of margin is worth roughly $0.30 of EPS. Persistence: the plan runs through FY2028 cost programmes.	Not available	+38.0%
Sport Performance Pipeline Rebuild	Nike's share slide to roughly 22.9% of global sports footwear was self-inflicted: lifestyle retro milked while running and training innovation stalled, handing Hoka and On the technical franchise. The remediation is underway through renewed running, basketball and training launches, and the 2028 Los Angeles Olympics gives a home-market amplification window. Product cycles in footwear run 18-30 months, so earnings benefit lands FY2028-FY2030 rather than immediately.	Not available	+20.0%
A 46% Yield Floor Beneath THE Price	At $35.50 the $1.64 annual dividend yields about 4.6%, a level Nike has never previously offered; twenty-four consecutive annual increases make a token 1-3% raise the path of least resistance. That income floor attracts value and dividend-mandate buyers who were structurally absent when the stock traded at 30x. The support is valuation-based rather than earnings-based, and strengthens as Treasury yields eventually retreat from 5%.	Not available	+18.0%
Inventory Clean FULL Price Returns	The Q4 FY2026 gross margin print of 49.2% flattered by tariff recovery still conceals a real signal: the liquidation cycle that crushed FY2025 margins is largely complete. Wholesale grew 6% to $27.5B as the marketplace reset absorbed excess units. As promotional intensity normalises, each point of recovered full-price mix converts directly into gross profit on a $46B base; this mechanically fades once the comparison laps in FY2028.	Not available	+15.0%

Primary frictions

Primary frictions supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
China IS Smaller NOT Merely Slower	Greater China revenue fell 11% to $5.9B in FY2026, an eighth consecutive quarterly decline, with Q4 down 12% to $1.3B [1]. This is not cyclical softness: domestic brands Anta and Li-Ning have taken permanent shelf and mindshare, and the supplied macro context shows Chinese nominal retail sales up only 0.4% YoY in August with property investment down 19.9%. China historically carried the group's highest margins, so the mix loss compounds the revenue loss.	Not available	-18.0%
Challenger Brands OWN THE Running LANE	On and Deckers' Hoka have converted performance credibility into premium pricing exactly where Nike's moat was deepest, and On's reported signing of Kylian Mbappe shows challengers can now outbid at the superstar tier [evidence memo]. Converse compounds the problem, down 31% for FY2026. Endorsement inflation and share defence raise demand-creation spend permanently, capping the operating-margin recovery well below the 15.6% achieved in FY2021.	Not available	-16.0%
Tariff Receivable Tariff Recurrence	FY2026 Q4 EPS of $0.72 included roughly $0.52 from an expected IEEPA tariff recovery, so headline TTM EPS of $2.10 and a 16.9x P/E overstate the earnings base [evidence memo]. Meanwhile the replacement Section 301 duties of 10-12.5% across 60 economies keep landed costs elevated for a Vietnam- and Indonesia-weighted sourcing base. Guidance already assumes 15% incremental tariffs; renegotiation risk runs in both directions through 2028.	Not available	-9.0%
Dividend Exceeds FREE CASH FLOW	FY2026 free cash flow of $2.18B funded $2.4B of dividends, a payout above 100% of FCF, while repurchases collapsed from $2.98B to about $123-146M [evidence memo]. The gap is currently bridged with balance-sheet cash, which fell $2.3B to $8.1B in FQ3. That arithmetic removes the buyback's per-share tailwind for at least two years and makes the dividend streak a constraint on reinvestment rather than a signal of strength.	Not available	-5.0%

Tail opportunities

Tail opportunities supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
China Stops Bleeding BY Fy2028	If the Greater China marketplace reset finishes and the region prints a flat-to-positive quarter during calendar 2028, the single most damaging narrative element disappears. The mechanism is violent because China carries above-group gross margin: a return to even $6.5B of revenue at recovered margin adds roughly $0.25-0.35 to EPS while simultaneously justifying a multiple closer to 20x normalised earnings rather than the current cyclical-turnaround rating. It stays below 50% because eight consecutive declining quarters and structurally stronger domestic competitors argue the base has shifted down permanently.	33.0%	+35.0%
LOS Angeles 2028 HOME Field Supercycle	A US-hosted Olympic Games in summer 2028 is the most favourable marketing backdrop Nike can receive, landing precisely when the rebuilt sport-performance pipeline should be in market. Triggered by strong athlete-signing wins and a credible innovation slate unveiled at Investor Day, it would lift full-price mix, reaccelerate North American growth above 5%, and let the market underwrite mid-teens operating margins again. Probability stays under 50% because Olympic halos historically fade within two quarters and On, Adidas and Hoka will contest the same window aggressively.	38.0%	+24.0%

Tail risks

Tail risks supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
THE Under Armour Trajectory	The bear terminal state is not a bad year but a structural de-rating: gross margin stalls near 43%, China keeps shrinking, and FY2028 EPS lands below $1.50 rather than the consensus $2.00. Trigger would be two consecutive quarters of negative North American wholesale sell-through alongside continued footwear share loss below 21%, most likely visible during 2027-2028. The market would then treat Nike as a mature licensor of heritage rather than a growth compounder. It remains under 50% because Nike's scale, sourcing leverage and distribution control still dwarf every challenger.	29.0%	-34.0%
THE Streak Breaks	If FY2027 free cash flow falls below $2B while dividends exceed $2.4B, management faces a choice between funding the payout from a shrinking $8.1B cash pile or holding the dividend flat and forfeiting a twenty-five-year increase record. A freeze or cut, most plausible in the November 2027 or November 2028 declaration window, would force dividend-mandate funds to sell mechanically and signal that the margin recovery has failed. Probability stays below 50% because a token 1-3% raise costs little and management is heavily motivated to preserve the record.	22.0%	-26.0%

Step-by-step forecast path

Universal Investor forecast path for prediction task predrqst_batch_task__xrefsubjtskconf_8a9201da-070f-511e-838b-37a416bdeb8d__sb7__20260920064920277661
Step	Forecast date	Step change	Projected value (USD)	Scenario rationale
1	December 18, 2026	-5.0%	33.73	The October 1 FQ1 print arrives without a tariff credit to flatter it, exposing underlying margin. S&P 100 deletion flows and guidance for a low-single-digit revenue decline keep sellers dominant into holiday discounting.
2	March 18, 2027	+2.0%	34.41	December-quarter results show gross margin inflecting on supply-chain cost actions rather than demand recovery. A streak-preserving dividend raise steadies income holders, and washed-out positioning permits a modest bounce from twelve-year lows.
3	June 18, 2027	+4.0%	35.79	Spring evidence that North American wholesale sell-through has stabilised with clean inventory lets investors underwrite margin recovery. Easing US inflation trims the discount rate applied to slow-growth consumer cash flows.
4	September 18, 2027	+4.0%	37.22	FY2027 closes with operating margin up year over year, validating the incentive-linked cost programme. FY2028 guidance restores low-single-digit growth, and the multiple starts normalising away from trough-sentiment levels.
5	December 18, 2027	+5.0%	39.08	Greater China's decline decelerates toward flat, removing the most damaging element of the bear narrative. Improved free cash flow allows a modest buyback restart, signalling management confidence and absorbing float.
6	March 18, 2028	+3.0%	40.25	Holiday share data show Nike holding ground against On and Hoka in performance running. The advance is earnings-delivered rather than re-rating, as investors still discount competitive intensity and elevated endorsement costs.
7	June 18, 2028	+4.0%	41.86	Los Angeles Olympics build-up lifts sport-performance visibility and full-price mix in the home market. Tariff assumptions are now annualised into the cost base, so gross margin comparisons turn cleanly positive.
8	September 18, 2028	+3.0%	43.12	Post-Olympic sell-through confirms the product pipeline rebuild is commercially real, not promotional. FY2028 operating margin approaching 9% supports the recovery arc, though China remains a structurally smaller contributor.
9	December 18, 2028	+3.0%	44.41	Free cash flow recovers above $3B, restoring dividend coverage and removing the payout-sustainability discount embedded in the valuation. Lower policy rates improve the relative appeal of a consumer cash-flow compounder.
10	March 18, 2029	+2.0%	45.30	Post-Olympic comparison difficulty caps the advance as North American growth normalises. Margin progression continues through sourcing and SG&A discipline, but the easy re-rating from capitulation valuations is now largely captured.
11	June 18, 2029	+3.0%	46.66	FY2029 results show revenue growth resuming in the low single digits with operating margin near 10%. The market shifts from debating survival of the brand to debating the terminal margin ceiling.
12	September 18, 2029	+2.0%	47.59	Buyback capacity expands as cash conversion improves, adding a modest per-share tailwind. Competitive spending by On and Adidas prevents faster multiple expansion despite steady operational execution and stable market share.
13	December 18, 2029	+3.0%	49.02	A strong holiday quarter with full-price mix at multi-year highs confirms pricing power has been rebuilt. Investors reprice Nike toward a mature quality-consumer multiple near nineteen times forward earnings.
14	March 18, 2030	+2.0%	50.00	Growth settles into a mid-single-digit cadence as the recovery matures. Incremental returns now come from earnings compounding and shrinking share count rather than from further sentiment normalisation.
15	June 18, 2030	+2.0%	51.00	World Cup-adjacent football product supports international momentum while China contributes stability rather than growth. Margin gains slow as demand-creation reinvestment rises to defend hard-won performance-category share.
16	September 18, 2030	+2.0%	52.02	FY2030 closes with operating margin near eleven percent, below the pre-2022 peak but well above the FY2026 trough. Valuation now reflects a durable but structurally lower-growth franchise.
17	December 18, 2030	+2.0%	53.06	Cash returns dominate the total-return story: a covered dividend plus consistent repurchases. Price appreciation tracks earnings growth closely, with limited scope for further multiple expansion from here.
18	March 18, 2031	+1.0%	53.59	Mature-phase drift. Category competition remains intense and Nike's global footwear share stabilises rather than recovers, capping revenue growth near four percent and constraining incremental valuation support.
19	June 18, 2031	+2.0%	54.66	Steady execution and disciplined capital allocation deliver predictable earnings growth. The stock behaves as a quality consumer compounder again, with volatility compressed relative to the 2026-2027 repricing period.
20	September 18, 2031	+2.0%	55.75	The five-year arc completes with earnings power restored to roughly $2.80 per share and a mid-fifties price. Returns beyond this point depend on renewed innovation rather than margin repair.

Advisor and configuration

Advisor: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release
Persona: Universal Investor
Archetype: The Polymath
Model: 2026-07-24 release
Provider: Anthropic
Mode: RESEARCHER (Web Search Enabled) with High Reasoning and Standard Creativity
Task configuration: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release__equity__json__extnd_invest_thesis_4q_alphassym__ts_num_desc__h5y_s3m__var1__researcher__standard_creativity_high_thinking__batch
Forecast horizon: 5 year
Forecast steps: 20 steps of 3 month
Assembly type: Balanced Assembly
Assembly name: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release RESEARCHER Forecast Assembly
Input format: inmemory_base_placeholders__latest_eod_close_price_with_stats_and_fundamentals__var1
Output format: Equity Extended Investment Thesis (4 Quadrants and Alpha Asymmetry) + Pct Change Timeseries for Close Price with Rationale, (5Y Quarterly)

Read the complete Universal Investor advisor methodology

Configuration components

aiassmprmtcmpnt_b995bbe2-6a15-55be-a576-525904f696e8
aiassmprmtcmpnt_c55d1851-d218-5d30-b83b-54bbda31e2ee
aiassmprmtcmpnt_930157b1-05d7-5699-bf0a-738645ee42fd
aiassmprmtcmpnt_3c0c459a-0d4a-50ca-87df-c172ec5618aa
aiassmprmtcmpnt_8115cc2a-d418-54b1-a616-49dfa91195f4

Research sources

[1]Nike stock hits 12-year low as turnaround stallseciks.org
[2]Nike posts Q4 2026 earnings beat, but tariff refunds mask China strugglesfinance.yahoo.com

Back to advisor navigation

End of the paywalled preview

The excerpt from Macro-regime alignment to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.

Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.

Other AI Advisor reports — limited previews

Sherlock Holmes — RESEARCHER (Web Search Enabled) with High Reasoning and Standard Creativity

Gemini 3.8 Flash

Limited structural preview, provided as simplified HTML. The complete report contains substantially more research: its investment thesis; bull and bear scenarios; macro-regime analysis; drivers, risks and opportunities; quarterly forecast tables and rationale; references and published configuration. Those findings and datasets are not included here. Sign in with the required subscription to open this advisor's full report.